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Objectives—Examine the effects of post-traumatic amnesia (PTA) duration on
neuropsychological and global recovery from 1 to 6 months after complicated mild traumatic brain
injury (cmTBI).
Participants—330 persons with cmTBI defined as Glasgow Coma Scale score of 13–15 in
Emergency Department, with well-defined abnormalities on neuroimaging.
Methods—Enrollment within 24 hours of injury with follow-up at 1, 3, and 6 months.
Measures—Glasgow Outcome Scale-Extended, California Verbal Learning Test II, Controlled
Oral Word Association Test. Duration of PTA was retrospectively measured with structured
interview at 30 days post injury.

Author Manuscript

Results—Despite all having a Glasgow Coma Score of 13–15, a quarter of the sample had a PTA
duration of greater than 7 days; half had PTA of 1–7 days. Both cognitive performance and GOS-E
outcomes were strongly associated with time since injury and PTA duration, with those with PTA>
1 week showing residual moderate disability at 6-month assessment.
Conclusions—Findings reinforce importance of careful measurement of duration of PTA to
refine outcome prediction and allocation of resources to those with cmTBI. Future research would
benefit from standardization in CT criteria and use of severity indices beyond GCS to characterize
cmTBI.
Keywords
traumatic brain injury; cognitive function; outcome measures; post-traumatic amnesia
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Author Manuscript

Based on estimates from the Centers for Disease Control and Prevention, there are more
than one million emergency department (ED) visits for head injury each year in the US, with
approximately 300,000 resulting hospitalizations.1 The vast majority are so-called mild
traumatic brain injuries (mTBI), which are at least tenfold more prevalent than more severe
injuries.2 While the likelihood of favorable recovery from mTBI within a few months is
high,3–5 a proportion of patients experience long-standing cognitive, emotional, and/ or
somatic symptoms that interfere with work, school, and/or family responsibilities.6 Thus, it
is likely that the societal burden resulting from mTBI is at least equivalent to that resulting
from severe TBI, given the considerably higher prevalence of the former.2, 6

Author Manuscript

One common definition of mTBI, put forth by the American Congress of Rehabilitation
Medicine (ACRM) in 1993, specifies a Glasgow Coma Scale (GCS) score of 13–15 in the
ED and loss of consciousness (LOC) ≤ 30 minutes.7 While some loss or alteration of
consciousness is necessary to signal a TBI by this definition, post-traumatic amnesia (PTA)
must not exceed 24 hours for the TBI to be considered mild. However, it has become
apparent that there are clinically important variations within the group of injuries that result
in GCS 13–15, which may help to explain the diverse outcomes experienced by this group of
patients. In 1990, Williams et al. used the term “complicated mild” TBI (cmTBI) to refer to
cases where GCS is 13–15 but there are CT abnormalities such as contusions or other
trauma-related brain lesions.8 Although the cmTBI patients in this sample did not differ
J Head Trauma Rehabil. Author manuscript; available in PMC 2017 November 01.
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from mTBI patients on LOC or PTA duration, their 6-month outcomes were worse. This led
the authors to suggest that an intracranial lesion should place such patients into the
“moderate” severity category, or at least into a different category from those with
uncomplicated mTBI. More recent work has suggested that as many as 30–50% of patients
with TBI presenting to the ED with GCS 13–15 may have trauma-related intracranial
pathology visible on CT.6, 9, 10

Author Manuscript

The research comparing outcomes of mTBI to those of cmTBI has been equivocal; it is
difficult to synthesize findings due to the generally small samples and the differences among
studies in how cmTBI was defined, the measures used (neuropsychological tests, symptom
checklists, global outcome measures, etc.), and the intervals at which outcomes were
measured, ranging from 1 week to 1 year. Several prospective9–11 and retrospective4 studies
have reported no or very small differences between cmTBI and mTBI in neuropsychological
test performance, return to work rates, or global outcomes. Others have found worse
outcomes for cmTBI on global outcome measures12 or neuropsychological tests.13 Two
reports from the ongoing TRACK-TBI project have reported worse global outcomes for
cmTBI compared to mTBI at 3 months, but differences had attenuated by 6 months.6, 14

Author Manuscript
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While all previous reports on cmTBI outcomes have used GCS 13–15 and positive CT
findings as defining characteristics, there is variation in the literature as to the inclusion of
other TBI severity indices, notably LOC (also known as Time to Follow Commands or TFC)
and PTA duration. A few studies have used the ACRM criteria for both mTBI and cmTBI
cases, meaning that LOC and PTA are brief for both groups and the only difference is the
presence of visible brain pathology.10, 14 Most others have focused on GCS and CT findings
to define the groups, and have not reported the other indices. LOC is difficult to measure
accurately in these patients since by definition, they are conscious in the ED, and LOC
duration would need to be determined by accounts of field rescue staff or other witnesses, all
of whom may be unavailable. However, PTA duration has been shown to vary widely in
patients who present to the ED with GCS 13–15, in many cases lasting well beyond the 24
hours stipulated in the ACRM definition of mTBI.15 PTA duration is considered the most
sensitive index of the degree of diffuse axonal injury (DAI)16 and can be measured
prospectively, using serial testing, or retrospectively using structured interviewing to
estimate the length of the gap in recall following the TBI. But a recent report pointed out
that PTA is not routinely assessed in the ED, and that many patients who are “fully oriented”
(GCS = 15) are found still to be in PTA when tested with more sensitive measures of
anterograde memory.17 Thus, it is possible that some of the variable results in the cmTBI
literature could be explained by differing amounts of DAI within the range insufficient to
cause deep or prolonged unconsciousness, which could nonetheless combine with focal
injuries to adversely affect outcomes.
A more comprehensive understanding of the determinants of cmTBI outcome is important
because of its prevalence among so-called mild brain injuries, because of the current
difficulty in predicting outcome for patients with this clinical presentation, and because
some people with cmTBI may require more extensive rehabilitation services than are
typically offered to them. In the current study, we performed a secondary analysis on a large
sample of persons with cmTBI who had been enrolled in the 8-center COBRIT
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neuroprotection trial.18, 19 Advantages of this dataset included capture of both
neuropsychological and global outcomes at 3 time points within the first 6 months after
injury; rigorous characterization of neuroimaging results used to diagnose cmTBI; and
standardized assessment of PTA duration. We examined the trajectory of recovery in 2
important cognitive domains as well as global outcome, hypothesizing that longer PTA
would be associated with worse outcomes after controlling for other variables known to
affect TBI outcome.

METHOD
Participants

Author Manuscript

Participants were a sub-group of those identified as having cmTBI in the COBRIT study, an
8-center, placebo-controlled Phase III trial examining the neuroprotective effects of
citicoline administered within 24 hours of injury.18, 19 COBRIT inclusion criteria were: nonpenetrating TBI of at least complicated mild severity (defined below); aged 18 (19 in
Alabama) to 70; sufficiently fluent in English to complete neuropsychological testing; and
able to provide consent by self or proxy within 24 hours of injury. Patients were excluded
from COBRIT if they were unlikely to survive to follow-up due either to the TBI or
associated injuries, pregnant, incarcerated, or had a history of significant psychiatric illness
(e.g., schizophrenia, suicide attempt in the past year) or neurological disorder (e.g., previous
TBI with hospitalization, stroke, dementia).
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For the current study, we selected patients from the inert-placebo arm of COBRIT who had
experienced cmTBI. Citicoline-treated participants were excluded because although the
parent trial showed no neuroprotective benefit of citicoline, there was some indication that
cmTBI patients did worse in the active drug condition.19 Thus, inclusion criteria for the
present study were: assignment to the placebo arm of the trial; GCS of 13–15 in the ED; and
evidence of one or more CT scan abnormalities at the time of study randomization, which
took place within 24 hours of injury. A scan abnormality was defined as any of the
following: ≥10 mm total diameter of all intraparenchymal hemorrhages; acute extra-axial
hematoma thickness ≥5 mm; subarachnoid hemorrhage visible on at least two contiguous 5mm slices or at least three contiguous 3-mm slices; intraventricular hemorrhage present on
two slices; or midline shift ≥5 mm. These criteria were established by a study team that
included neurosurgeons, neurologists, and physiatrists, with input from neuroradiologists, so
as to avoid enrolling patients with equivocal TBI into the COBRIT study19 and to minimize
inter-observer variation across sites.20 All CT scans were read by neuroradiologists at the
participating sites who had received training in the COBRIT study protocol. The scans were
subsequently reviewed by a panel of neurosurgeons and neurologists associated with the
study to ensure adherence to inclusion guidelines.

Author Manuscript

Measures
Outcome was assessed at 30 (+/− 7), 90 (+/− 10), and 180 (+/− 10) days post injury with a
battery that included the following measures.

J Head Trauma Rehabil. Author manuscript; available in PMC 2017 November 01.
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Extended Glasgow Outcome Scale(GOS-E):21—The GOS-E consists of eight levels
of functional recovery, ranging from Dead (0) to Good Recovery (8). Items comprising the
scale focus on the capacity to care for oneself and function in the community, as well as
effects of persistent TBI symptoms interfering with function. The GOS-E is commonly
employed to measure functional recovery following TBI including cmTBI6, 12, 14 and has
demonstrated good test-retest reliability (r = .92).22
California Verbal Learning Test-II:23—The CVLT-II requires the individual to learn a
list of 16 words over 5 trials. For this study, we used the T score for the sum of the 5
learning trials. The CVLT-II and its predecessor (CVLT) have proven to be sensitive
measures of memory disorder after TBI,24, 25 and the revised form has good test-retest
reliability (r = .82). 23 To minimize practice effects, the standard form of the CVLT-II was
administered at the 30- and 180-day intervals and the alternate version at the 90-day interval.
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Controlled Oral Word Association Test (COWAT):26—In this test of verbal
generativity, subjects are allowed 60 seconds to say as many words as possible that begin
with a specific letter of the alphabet. Verbal fluency is commonly impaired following TBI,
probably reflecting executive dysfunction more than linguistic impairment.27, 28 In this
study, the total number of words produced was analyzed after correction for age and
education. The PRW version of the COWAT was administered at the 30-day interval and the
CFL form at 90 and 180 days. These forms have been shown to be equivalent,29 and the
COWAT overall has adequate test-retest reliability (r = .74).30

Author Manuscript

Post-Traumatic Amnesia—PTA duration was measured retrospectively using a 5–10minute structured interview in which a trained data collector assisted the participant in
estimating the number of days or, if <1 day, the number of hours, between the TBI and
resumption of continuous recall of events. The interview took place at the first follow-up
assessment at which the participant achieved a score of greater than 75 on the Galveston
Orientation and Amnesia Test (GOAT).31 In nearly all cases of cmTBI, this was 30 days post
injury. This interview has been used in prior studies of TBI.32, 33 It has demonstrated
construct validity in that PTA intervals based on the interview were shown to be
monotonically related to psychiatric outcomes, with longer PTA predicting worse outcomes
in the same cohort as studied in this investigation.34 In another study, PTA durations
ascertained using the interview correlated well with PTA prospectively measured using serial
orientation testing, even in patients interviewed months or years after TBI (n = 35; r = 0.68,
p<.001).35 For this study we collapsed PTA durations into 3 levels: <24 hours (i.e.,
comparable to ACRM criterion for mTBI);7 1–7 days; and >7 days.

Author Manuscript

Procedures
The institutional review boards (IRB) of all participating sites approved the protocol and
either the patients or their legally authorized representatives (LAR) provided written
informed consent according to the local IRB rules for proxy consent. If an LAR consented
originally, the participant directly consented for continued involvement upon recovery of
decision-making capacity. Data collection was performed according to a manualized
procedure. All data were double-scored at each site, and monthly teleconferences were held
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among data collectors and investigators at each site to address questions of test
administration, scoring, or coding. A Data Coordinating Center at Columbia University
oversaw the trial, cleansed the data, and performed preliminary analyses. Upon completion
of the COBRIT trial, de-identified data were provided to all participating sites.
Data Analysis

Author Manuscript

Chi-square tests were used to examine the associations of PTA with demographic variables
and mechanism of injury. For the analyses of neuropsychological and global outcomes by
PTA group, all outcome measures in the battery were treated as continuous variables.
Predictors were all categorical. Descriptive analyses consisted of frequencies, means, and
plots. Separate linear mixed effects models were used to evaluate each of the longitudinal
outcomes. Preliminary model fitting evaluated demographic variables and mechanism of
injury as predictors of each individual outcome. Potential confounding variables were
selected based on best fit as assessed by Akaike’s information criteria.36 Next, PTA group
was added to each of the models. Contrasts within the linear mixed effects analysis
compared the PTA groups and the change between consecutive assessments. Participants
were excluded from the analysis if they were missing all 3 assessments, racial/ethnic group,
education, or PTA duration. As is common in studies of TBI, participants who could not
perform the tests due to cognitive difficulties associated with the TBI were assigned 1 raw
score unit worse than the lowest observed score on the CVLT-II and COWAT.37, 38 Ten
participants could not perform either neuropsychological measure at 30 days, and one could
not perform COWAT. One participant could not perform either measure at 90 days due to
cognitive difficulties. One participant died before the 180-day evaluation. His data were
included until death, and then assigned a value 1 lower than that assigned to those too
cognitively impaired to take the CVLT-II and COWAT. This was done because unlike the
GOS-E, the neuropsychological measures do not have a score indicating death, and we
preferred to maintain this participant’s data on all measures via use of arbitrarily low scores.

Author Manuscript

RESULTS
The COBRIT study included 401 participants with cmTBI who were randomly assigned to
the placebo group. Of these, 53 individuals had no outcome assessments; 6 were missing
race/ ethnicity or education data; and 12 had unknown PTA, leaving a sample of 330.
Analyses were separately conducted for GOS-E (n=330), COWAT (n=328) and CVLT-II
(n=317).

Author Manuscript

Demographics and mechanism of injury for the PTA groups are summarized in Table 1. It is
apparent that there was a wide range of PTA duration in this sample, despite all participants
having an ED GCS of 13–15. Only 25% of the sample had PTA < 1 day, while 47% had
PTA of 1–7 days and 28% reported > 7 days. Not surprisingly, participants involved in motor
vehicle collisions were significantly more likely to have longer PTA durations than those
injured by falls or assault. PTA duration was not significantly associated with age, sex, race/
ethnicity, or education.
Figure 1 displays the 3 outcome measures for each PTA group at each outcome assessment.
It may be seen that the shortest PTA group has the highest, and the longest PTA group the
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lowest, mean score at each time point on all 3 measures. For the GOS-E, at 1 month after
injury, participants with PTA > 7 days were functioning, on average, in the moderate to
severe disability range, while those experiencing briefer PTA duration were mostly in the
moderate disability category. The shorter PTA groups improved to the good recovery range
by 6 months post-injury, while the longest duration PTA group had only reached the upper
moderate disability range on average. Clinically, upper moderate disability means that there
are restrictions in the capacity to work at the premorbid level, and/ or limitations in social/
leisure activity participation, and/ or frequent disruption in family or friendship relationships
attributable to the injury.

Author Manuscript

The pattern was similar overall for the neuropsychological measures. For the CVLT-II, total
learning performance for the > 7 days PTA group fell within the borderline impaired range
at 30 days on average, and scores increased to the average range by 6 months post-injury.
Those with shorter duration PTA fell within the average range even at 1 month, but still
increased over the next two administrations; the PTA <1 day group reached the high average
range at 6 months after injury. Finally, on the COWAT, the long duration PTA group
exhibited low average performance at 1 month that increased to average performance in
subsequent administrations. The shorter PTA groups demonstrated average performance on
the COWAT at all intervals.

Author Manuscript

Post-hoc rank order correlations among the 3 outcome measures were calculated in an
attempt to shed light on the apparent discrepancy between cognitive and functional recovery,
particularly in the group with the longest PTA duration. At the 180-day evaluation, CVLT-II
and COWAT scores were moderately intercorrelated (rho = .42, p<.001). GOS-E scores were
more weakly correlated with either cognitive measure (rho = .22 for CVLT-II, .15 for
COWAT), although both were significant at p<.01 given the large sample size.
The initial mixed models indicated that age and race were potential predictors for GOS-E;
age, sex, and education were potential confounders for COWAT; and age, race, and
education were potential confounders for CVLT-II. Addition of PTA as a predictor
significantly improved all three models. Table 2 gives the coefficients for the three models.
Each outcome was strongly related to both time of observation and PTA group (each p
<0.002). Contrasts are shown in Table 3. Compared to 30 days, scores improved
significantly by 90 days and again from 90 to 180 days for each measure. Those with PTA
>7 days had significantly worse outcome than either those with PTA <1 day or PTA 1–7
days on each measure (each p <0.001). Those with PTA <1 day had significantly better
outcome than those with 1–7 days of PTA on GOS-E and CVLT-II, but the differences were
less robust.

Author Manuscript

DISCUSSION
In a large, prospectively followed cohort of persons with cmTBI, all with GCS 13–15 in the
ED and strictly defined CT scan abnormality, we observed a wide range of PTA duration that
was strongly related to neuropsychological and global outcome within the first 6 months of
injury. Only a quarter of the sample had resolution of PTA within 24 hours, the duration
typically associated with mild TBI.7 Nearly half experienced PTA of 1–7 days, with the
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remaining 28% reporting more than a week of PTA. That longer PTA duration was
associated with worse performance on tests of memory and verbal fluency, in addition to
worse global outcome, suggests that PTA is an important measure in cases of cmTBI, just as
in uncomplicated mild TBI.15 From a research perspective, including PTA along with GCS
and neuroimaging may help to reduce the discrepancies among study findings as well as
helping us to understand the relative contributions of diffuse and focal brain injury to
ultimate outcome. Clinically, ascertaining PTA in addition to GCS and CT findings should
assist both in predicting recovery and in recommending rehabilitation services in cases of
cmTBI. A brief retrospective interview such as the one described here could be administered
shortly after the resolution of PTA or at a clinic follow-up and is substantially less laborintensive than prospective tracking of anterograde learning ability, particularly in a busy ED
or acute hospital setting. While PTA duration is potentially useful as a predictor in all cases
of TBI, it is especially important to ascertain when the mechanism of injury is motor vehicle
collision, as our data confirm that prolonged PTA (and presumably, more DAI) is more
likely with this cause of TBI.
It is important to note that for all PTA duration groups, we observed continued improvement
on all measures between all pairs of time points used in this investigation (1, 3, and 6
months). This attests to the sensitivity of the measures selected as well as the need for
continued follow-up of cmTBI patients. Specifically, it would be useful for future research,
as well as clinical services, to follow persons with cmTBI for longer than 6 months to
capture the full recovery trajectory. This is particularly important for those with longer PTA,
as the average participant with duration >1 week still reported limitations in social and/ or
vocational functioning at 6 months after injury.
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Regarding this last point, one limitation of this study is that we lack detailed information
that might help to explain the residual disability of the group with the longest PTA.
Although correlations between GOS-E and cognitive scores at 6 months were statistically
significant, they were small in magnitude. In TBI it is not unusual to find normal
psychometric test performance in the face of greater difficulty in less structured, real-world
situations.39 Other unmeasured factors could also be contributing to the GOS-E outcomes;
these could include persistent post-concussive symptoms such as headache or insomnia,
post-traumatic stress, irritability, or other emotional dysfunction; or cognitive dysfunction
that could have been picked up by the use of more demanding measures, e.g., of
information-processing speed.

Author Manuscript

Our findings may be difficult to compare to previous reports on cmTBI due to differences in
the definition of the samples, especially with regard to the CT abnormalities. Our sample
may have been skewed toward more serious cases of cmTBI due to the stringent CT scan
criteria we employed. For example, a minor subarachnoid hemorrhage would have excluded
a patient from the COBRIT study but perhaps not from other investigations of this
population. However, many studies of cmTBI do not specify the CT abnormalities that
qualify a patient for inclusion. In future, we recommend clear and precise definitions of CT
criteria for cmTBI to improve the cross-walk between studies. To the extent that studies may
be compared, our findings generally comport with previous work showing scores in the
normal range at 3–6 months after cmTBI with respect to CVLT-II total learning40 and
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COWAT performance.8 However, as documented in this study, those with PTA >7 days
achieve these results more slowly and even at 6 months are not performing as well as those
with shorter PTA.
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Other than those noted above, several limitations of this study must be acknowledged. The
study was limited to persons with cmTBI and lacked any sort of control or comparison
group. A comparison group of patients with uncomplicated mTBI, as in the work of Yuh and
colleagues,14 would have allowed us to estimate the effects of focal cerebral injury; however,
unless the ACRM definition had been disregarded and PTA duration allowed to vary, this
comparison would have offered little information as to the effects of diffuse injury that may
prolong alteration of consciousness. An uninjured control group may have helped to assess
the effects of serial testing on the cognitive measures; however, practice effects were
minimized by use of equivalent alternate forms. Finally, participants in the current study
were enrolled in the placebo arm of a treatment study, and there may have been an
expectation of improvement that affected performance.
In conclusion, these findings highlight the importance of assessing PTA duration to refine
outcome predictions and rehabilitation treatment recommendations for people who
experience cmTBI. Those with PTA > 1 week, in particular, may be at risk for residual
disability as long as 6 months following injury. Specifying both PTA duration and CT
criteria for cases of cmTBI will help to improve both comparisons across studies of this
population and future clinical service provision.
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Figure 1.
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Outcome measures for each PTA group. (A) Performance on the GOS-E based on time and
PTA duration. (B) Performance on the learning trials of the CVLT-II based on time and PTA
duration using T score. (C) Performance on the COWAT based on time and PTA duration
with raw score adjusted for age and education. Observed values include death. Error bars are
±1 SE of the mean. GOS-E indicates Glasgow Outcome Scale-Extended; CVLT-II,
California Verbal Learning Test II; COWAT, Controlled Oral Word Association Test.

Author Manuscript
J Head Trauma Rehabil. Author manuscript; available in PMC 2017 November 01.

Hart et al.

Page 13

Table 1

Author Manuscript

Demographics and mechanism of injury by PTA group
PTA <1 day n = 84

PTA 1-7 days n = 155

PTA >7 days n = 91

18–30

21 (25%)

44 (28%)

20 (22%)

>30–45

14 (17%)

40 (26%)

26 (29%)

>45–60

29 (35%)

49 (32%)

31 (34%)

>60

20 (24%)

22 (14%)

14 (15%)

Female

17 (20%)

47 (30%)

29 (32%)

Male

67 (80%)

108 (70%)

62 (68%)

White

64 (76%)

126 (81%)

76 (84%)

Black/African American

13 (15%)

22 (14%)

12 (13%)

Hispanic

7 (8%)

7 (5%)

3 (3%)

Some elementary school or high school

11 (13%)

20 (13%)

13 (14%)

High school graduate, GED, technical, vocational, or trade school

27 (32%)

64 (41%)

36 (40%)

Some college

23 (27%)

42 (27%)

20 (22%)

College graduate, some graduate school, or completed graduate
school

23 (27%)

29 (19%)

21 (23%)

Missing/Unknown

0 (0%)

0 (0%)

1 (1%)

Motor vehicle collision

26 (31%)

73 (47%)

60 (66%)

Fall from moving object

14 (17%)

20 (13%)

3 (3%)

Fall from stationary object

24 (29%)

39 (25%)

20 (22%)

Assault (Intentional Injury)

15 (18%)

16 (10%)

6 (7%)

Other

5 (6%)

7 (5%)

2 (2%)

Age

Sex

Race/Ethnicity

Author Manuscript

Education

Mechanism of Injury*

Author Manuscript

Abbreviations: PTA, post-traumatic amnesia

*

Significantly associated with PTA at p < .001
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Table 2

Author Manuscript

Final longitudinal model for GOS-E, COWAT, and CVLT-II at 30, 90, and 180 days after injury
GOS-E

Estimate

Lower 95% CI

Upper 95% CI

Time

p-valuea
<0.001

180 days (vs. 30 days)

1.20

1.06

1.34

<0.001

90 days (vs. 30 days)

0.86

0.73

1.00

<0.001

<1 day (vs. >7 days)

1.42

1.12

1.71

<0.001

1–7 days (vs. >7 days)

1.05

0.79

1.31

<0.001

PTA

<0.001

Age

0.001

Author Manuscript

>60 (vs. 18–30)

−0.57

−0.91

−0.23

0.001

46–60 (vs. 18–30)

−0.46

−0.76

−0.17

0.002

31–45 (vs. 18–30)

−0.10

−0.41

0.21

0.522

Race

0.010

Black (vs. White)

−0.48

−0.80

−0.17

0.003

Hispanic (vs. White)

0.03

−0.47

0.53

0.913

COWAT

Estimate

Lower 95% CI

Upper 95% CI

Time

p-value
<0.001

180 days (vs. 30 days)

6.58

5.51

7.66

<0.001

90 days (vs. 30 days)

5.54

4.65

6.43

<0.001

<1 day (vs. >7 days)

6.34

3.40

9.28

<0.001

1–7 days (vs. >7 days)

4.05

1.52

6.59

0.002

PTA

<0.001

Author Manuscript

Education

<0.001

College (vs. no HS)

9.59

5.85

13.33

<0.001

Some college (vs. no HS)

8.31

4.72

11.90

<0.001

HS/Other (vs. no HS)

3.20

−0.18

6.58

0.063

Sex (Female vs. Male)

2.50

0.08

4.91

0.043

>60 (vs. 18–30)

−5.57

−8.96

−2.17

0.001

46–60 (vs. 18–30)

−2.41

−5.20

0.39

0.091

31–45 (vs. 18–30)

−2.08

−5.11

0.95

0.178

CVLT-II

Estimate

Lower 95% CI

Upper 95% CI

p-value

Age

0.016

Author Manuscript

Time

<0.001

180 days (vs. 30 days)

11.11

9.75

12.47

<0.001

90 days (vs. 30 days)

6.04

4.73

7.35

<0.001

PTA
<1 day (vs. >7 days)

<0.001
7.55

4.35

10.75

<0.001
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CVLT-II

Estimate

Lower 95% CI

Upper 95% CI

p-value

1–7 days (vs. >7 days)

4.54

1.76

7.32

0.001

Author Manuscript

Race

<0.001

Black (vs. White)

−6.32

−9.68

−2.97

<0.001

Hispanic (vs. White)

−6.50

−11.87

−1.12

0.018

Education

<0.001

College (vs. no HS)

10.26

6.17

14.34

<0.001

Some college (vs. no HS)

8.23

4.27

12.20

<0.001

HS/Other (vs. no HS)

2.77

−0.98

6.39

0.150

Age

0.053

>60 (vs. 18–30)

−3.56

−7.27

0.16

0.060

46–60 (vs. 18–30)

−1.73

−4.75

1.28

0.260

31–45 (vs. 18–30)

−4.37

−7.69

−1.05

0.010

Author Manuscript

Abbreviations: GOS-E, Glasgow Outcome Scale-Extended; CI, confidence interval; PTA, post-traumatic amnesia; HS, high school; COWAT,
Controlled Oral Word Association Test; CVLT-II, California Verbal Learning Test II.

a
The p-value on the line with the variable name reflects the entire multicategory variable, whereas the p-value on the line with a category reflects
the comparison of that category with the reference category (indicated after ‘vs.’).
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Table 3

Author Manuscript

Comparison of PTA groups and assessment times
GOS-E
Contrasts

Difference

Lower 95% CI

Upper 95% CI

p-value

<1 day vs1–7 days

0.37

0.10

0.64

0.007

<1 day vs >7 days

1.42

1.12

1.71

<0.001

1–7 days vs >7 days

1.05

0.79

1.31

<0.001

30 vs 90 days

0.86

0.73

1.00

<0.001

90 vs 180 days

0.33

0.20

0.47

<0.001

Contrasts

Difference

Lower 95% CI

Upper 95% CI

p-value

<1 day vs 1–7 days

2.28

−0.35

4.91

0.089

<1 day vs >7 days

6.34

3.40

9.28

<0.001

1–7 days vs >7 days

4.05

1.52

6.59

0.002

30 vs 90 days

5.54

4.65

6.43

<0.001

90 vs 180 days

1.04

0.04

2.05

0.043

Contrasts

Difference

Lower 95% CI

Upper 95% CI

p-value

<1 day vs 1–7 days

3.01

0.15

5.87

0.039

<1 day vs >7 days

7.75

4.35

10.75

<0.001

1–7 days vs >7 days

4.54

1.76

7.32

0.001

30 vs 90 days

6.04

4.73

7.35

<0.001

90 vs 180 days

5.07

3.71

6.42

<0.001

COWAT

Author Manuscript

CVLT-II

Author Manuscript

Abbreviations: GOS-E, Glasgow Outcome Scale-Extended; CI, confidence interval; PTA, post-traumatic amnesia; COWAT, Controlled Oral Word
Association Test; CVLT-II, California Verbal Learning Test II.
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